Development of an Amplicon Nanopore Sequencing Strategy for Detection of Mutations Conferring Intermediate Resistance to Vancomycin in Staphylococcus aureus Strains
ABSTRACT Staphylococcus aureus is a major cause of bacteremia and other hospital-acquired infections. The cell-wall active antibiotic vancomycin is commonly used to treat both methicillin-resistant (MRSA) and sensitive (MSSA) infections. Vancomycin intermediate S. aureus (VISA) variants can arise th...
Main Authors: | Abraham G. Moller, Robert A. Petit, Michelle H. Davis, Timothy D. Read |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2023-02-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.02728-22 |
Similar Items
-
Effect of genetic background on the evolution of Vancomycin-Intermediate Staphylococcus aureus (VISA)
by: Michelle Su, et al.
Published: (2021-07-01) -
Alpha-amyrin as an anti-biofilm agent against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus
by: Pooi Yin Chung, et al.
Published: (2023-07-01) -
Resistance and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
by: Liang J, et al.
Published: (2023-01-01) -
Prevalence of Vancomycin Resistance in Methicillin-Resistant Staphylococcus Aureus
by: Parviz Mohajeri, et al.
Published: (2014-12-01) -
Staphylococcus aureus : molecular and clinical aspects /
by: Ala'Aldeen, Dlawer A. A., et al.
Published: (c200)